However, in human lung adenocarcinoma cells, NC efficacy was inversely correlated with the expression level of the drug transporter ABCA1: cancer cells with downregulated ABCA1 were more sensitive to NC treatment (Iwasaki et al., 2010). Here, ABCA1 is linked to lung adenocarcinoma.